We report 30-day, 1-year, and 3-year outcomes for a new TAVR programme that used five different transcatheter heart valve (THV) systems. From 2014 to 2020, 122 consecutive patients with severe aortic stenosis (AS) received TAVR based on the Heart Team decision. Outcomes were analysed for the whole study population and in addition the first 63 patients (Cohort A, 2014 to 2019) were compared to the last 59 patients (Cohort B, 2019 to 2020).
View Article and Find Full Text PDFTo report our single-center data regarding the initial 52 consecutive patients with a bicuspid aortic valve who underwent a Transcatheter Aortic Valve Implantation (TAVI) procedure using the new balloon-expandable MYVAL system. The focus is on reporting procedural details and outcomes over the 30-day postoperative period. From December 2019 to July 2023, 52 consecutive patients underwent a TAVI procedure with bicuspid anatomy.
View Article and Find Full Text PDFAims: To report our single-center data, regarding the first 100 patients who underwent TAVR procedure with the new balloon-expandable MYVAL system. We report 30-day and 1-year outcomes in low to high-risk TAVR patient population.
Methods: From November 2019 to July 2021, 100 consecutive patients underwent TAVR procedure.
Introduction: Several studies have demonstrated that the prevalence of heart disease can be accounted for between 0.4 and 2% in developed countries.
Aim: The present study aimed to use the PA% of the telemetry data to estimate the 6-minute walk test result.
Introduction: The effect of regular physical activity on health is widely recognized, but several studies have shown its key importance for heart patients.
Aim: The present study aimed to define the PA % values, and to convert them into metabolic equivalent values (MET), which describes oxygen consumption during physical activity.
Method: A total of seventeen patients with heart disease; 3 females and 14 males; age: 57.